Role of anti-GQ1B antibody in differential diagnosis of acute ophthalmoparesis

E Ece Boylu, R Erdem Togrol, Mehmet Güney Şenol, M Fatih Özdag, Mehmet SaraçogluGATA Hadarpaşa Educational and Research Hospital, Department of Neurology, Istanbul, TurkeyAbstract: Miller Fisher syndrome (MFS) is a triad of total external ophthalmoplegia, ata...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: E Ece Boylu, R Erdem Togrol, Mehmet Güney Şenol, et al
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2010
Materias:
Acceso en línea:https://doaj.org/article/a69dcbad8fd34466a022f4c3c3181933
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:a69dcbad8fd34466a022f4c3c3181933
record_format dspace
spelling oai:doaj.org-article:a69dcbad8fd34466a022f4c3c31819332021-12-02T06:33:36ZRole of anti-GQ1B antibody in differential diagnosis of acute ophthalmoparesis1176-63281178-2021https://doaj.org/article/a69dcbad8fd34466a022f4c3c31819332010-04-01T00:00:00Zhttp://www.dovepress.com/role-of-anti-gq1b-antibody-in-differential-diagnosis-of-acute-ophthalm-a4208https://doaj.org/toc/1176-6328https://doaj.org/toc/1178-2021E Ece Boylu, R Erdem Togrol, Mehmet Güney Şenol, M Fatih Özdag, Mehmet SaraçogluGATA Hadarpaşa Educational and Research Hospital, Department of Neurology, Istanbul, TurkeyAbstract: Miller Fisher syndrome (MFS) is a triad of total external ophthalmoplegia, ataxia, and areflexia, while botulism has the usual clinical presentation of involvement of cranial muscles and palsies with blurred vision, diplopia, ptosis, dilated pupils, and facial paralysis, caused by a bacterial neurotoxin which attacks proteins involved in presynaptic vesicle release. In this report, we needed to make the differential diagnosis between MFS and botulism in a patient who presented with acute ophthalmoparesis and a history of diarrhea three days before, which started two days after consuming tinned food. Routine laboratory, neurophysiologic, and imaging investigations were normal. A clinical diagnosis of Miller Fisher syndrome was reached by anti-ganglioside GQ1B and GM1 Ig G and M antibody investigations which proved positive. The patient was treated with intravenous immunoglobulin two weeks after (in the late period) the symptoms started and he has recovered completely. Systemic autoimmune diseases should be considered in patients with bilateral ophthalmoparesis. As in the present patient, the evaluation of specific antibodies helps in the diagnosis and thus early effective treatment is possible.Keywords: anti-ganglioside antibody, botulism, Miller Fisher syndrome, ophthalmoparesis E Ece BoyluR Erdem TogrolMehmet Güney Şenolet alDove Medical PressarticleNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol 2010, Iss Issue 1, Pp 119-122 (2010)
institution DOAJ
collection DOAJ
language EN
topic Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
spellingShingle Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
E Ece Boylu
R Erdem Togrol
Mehmet Güney Şenol
et al
Role of anti-GQ1B antibody in differential diagnosis of acute ophthalmoparesis
description E Ece Boylu, R Erdem Togrol, Mehmet Güney Şenol, M Fatih Özdag, Mehmet SaraçogluGATA Hadarpaşa Educational and Research Hospital, Department of Neurology, Istanbul, TurkeyAbstract: Miller Fisher syndrome (MFS) is a triad of total external ophthalmoplegia, ataxia, and areflexia, while botulism has the usual clinical presentation of involvement of cranial muscles and palsies with blurred vision, diplopia, ptosis, dilated pupils, and facial paralysis, caused by a bacterial neurotoxin which attacks proteins involved in presynaptic vesicle release. In this report, we needed to make the differential diagnosis between MFS and botulism in a patient who presented with acute ophthalmoparesis and a history of diarrhea three days before, which started two days after consuming tinned food. Routine laboratory, neurophysiologic, and imaging investigations were normal. A clinical diagnosis of Miller Fisher syndrome was reached by anti-ganglioside GQ1B and GM1 Ig G and M antibody investigations which proved positive. The patient was treated with intravenous immunoglobulin two weeks after (in the late period) the symptoms started and he has recovered completely. Systemic autoimmune diseases should be considered in patients with bilateral ophthalmoparesis. As in the present patient, the evaluation of specific antibodies helps in the diagnosis and thus early effective treatment is possible.Keywords: anti-ganglioside antibody, botulism, Miller Fisher syndrome, ophthalmoparesis
format article
author E Ece Boylu
R Erdem Togrol
Mehmet Güney Şenol
et al
author_facet E Ece Boylu
R Erdem Togrol
Mehmet Güney Şenol
et al
author_sort E Ece Boylu
title Role of anti-GQ1B antibody in differential diagnosis of acute ophthalmoparesis
title_short Role of anti-GQ1B antibody in differential diagnosis of acute ophthalmoparesis
title_full Role of anti-GQ1B antibody in differential diagnosis of acute ophthalmoparesis
title_fullStr Role of anti-GQ1B antibody in differential diagnosis of acute ophthalmoparesis
title_full_unstemmed Role of anti-GQ1B antibody in differential diagnosis of acute ophthalmoparesis
title_sort role of anti-gq1b antibody in differential diagnosis of acute ophthalmoparesis
publisher Dove Medical Press
publishDate 2010
url https://doaj.org/article/a69dcbad8fd34466a022f4c3c3181933
work_keys_str_mv AT eeceboylu roleofantigq1bantibodyindifferentialdiagnosisofacuteophthalmoparesis
AT rerdemtogrol roleofantigq1bantibodyindifferentialdiagnosisofacuteophthalmoparesis
AT mehmetgampuumlneysenol roleofantigq1bantibodyindifferentialdiagnosisofacuteophthalmoparesis
AT etal roleofantigq1bantibodyindifferentialdiagnosisofacuteophthalmoparesis
_version_ 1718399893297430528